Delivery Order SPE2DB24D3015-SPE2DB25FGAMH
- Not listed
- The Defense Logistics Agency awarded a $7,352.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) under contract number 4569037002. The delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action stemming from...
- The Defense Logistics Agency awarded a delivery order valued at $14,704.98 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed price structure. This delivery order, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,117.58 to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in quantities of 120 units. This non-competitive, firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and employs firm fixed pricing. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.49 to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price, non-set-aside contract represents a specific pharmaceutical delivery under AmerisourceBergen's broader federal supply arrangements. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, supporting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,558.78 on August 11, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract is scheduled for ultimate completion on September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 30-unit packages of Erleada 240 mg tablets valued at $7,352.49 under a firm fixed price contract. The award was made on August 14, 2025, with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. Performance will be executed from the awardee's corporate office located in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Erleada 60 mg tablets in quantities of 120 units. This contract, valued at $7,558.78 with a firm fixed price structure, represents a non-set-aside competitive award and is scheduled for completion by August 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in a quantity of 120 units, with a ceiling value of $7,558.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 11, 2025, with an ultimate completion date of September 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAMHDelivery Order
The Defense Logistics Agency awarded a $14,704.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) with a completion date of September 2, 2025. This non-competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location, supplying the medication to support federal medical procurement needs. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health Agency's pharmaceutical supply chain, leveraging its comprehensive Pharmaceutical Prime Vendor Global Program vehicle to distribute brand-name and generic medications across multiple therapeutic domains to military and veteran healthcare systems. The company's extensive federal contracting portfolio demonstrates its capability to deliver specialized pharmaceutical products competitively and efficiently. This delivery order for Erleada, an oncology medication, exemplifies the breadth of therapeutic commodities the vendor supplies through its established relationships with DLA's medical logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 8/11/25 |